| Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression Y Shirayama, ACH Chen, S Nakagawa, DS Russell, RS Duman Journal of Neuroscience 22 (8), 3251-3261, 2002 | 2101 | 2002 |
| R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects C Yang, Y Shirayama, JC Zhang, Q Ren, W Yao, M Ma, C Dong, ... Translational psychiatry 5 (9), e632-e632, 2015 | 542 | 2015 |
| Expression of the cAMP response element binding protein (CREB) in hippocampus produces an antidepressant effect ACH Chen, Y Shirayama, KH Shin, RL Neve, RS Duman Biological psychiatry 49 (9), 753-762, 2001 | 438 | 2001 |
| Correlation between plasma levels of glutamate, alanine and serine with severity of depression H Mitani, Y Shirayama, T Yamada, K Maeda, CR Ashby Jr, R Kawahara Progress in neuro-psychopharmacology and biological psychiatry 30 (6), 1155-1158, 2006 | 404 | 2006 |
| Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect SS Newton, J Thome, TL Wallace, Y Shirayama, L Schlesinger, N Sakai, ... Journal of Neuroscience 22 (24), 10883-10890, 2002 | 365 | 2002 |
| Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant‐like effects Y Shirayama, H Ishida, M Iwata, G Hazama, R Kawahara, RS Duman Journal of neurochemistry 90 (5), 1258-1268, 2004 | 336 | 2004 |
| Antidepressant effects of TrkB ligands on depression-like behavior and dendritic changes in mice after inflammation J Zhang, J Wu, Y Fujita, W Yao, Q Ren, C Yang, S Li, Y Shirayama, ... International Journal of Neuropsychopharmacology 18 (4), pyu077, 2015 | 281 | 2015 |
| Neurochemistry of the nucleus accumbens and its relevance to depression and antidepressant action in rodents Y Shirayama, S Chaki Current neuropharmacology 4 (4), 277-291, 2006 | 275 | 2006 |
| Negative Correlation between Brain Glutathione Level and Negative Symptoms in Schizophrenia: A 3T 1H-MRS Study D Matsuzawa, T Obata, Y Shirayama, H Nonaka, Y Kanazawa, ... PloS one 3 (4), e1944, 2008 | 239 | 2008 |
| High occupancy of sigma-1 receptors in the human brain after single oral administration of fluvoxamine: a positron emission tomography study using [11C] SA4503 M Ishikawa, K Ishiwata, K Ishii, Y Kimura, M Sakata, M Naganawa, K Oda, ... Biological psychiatry 62 (8), 878-883, 2007 | 170 | 2007 |
| Reduction of substance P after chronic antidepressants treatment in the striatum, substantia nigra and amygdala of the rat Y Shirayama, H Mitsushio, M Takashima, H Ichikawa, K Takahashi Brain research 739 (1-2), 70-78, 1996 | 168 | 1996 |
| Beta-hydroxybutyrate, an endogenic NLRP3 inflammasome inhibitor, attenuates stress-induced behavioral and inflammatory responses T Yamanashi, M Iwata, N Kamiya, K Tsunetomi, N Kajitani, N Wada, ... Scientific reports 7 (1), 7677, 2017 | 157 | 2017 |
| Correlation of plasma neurosteroid levels to the severity of negative symptoms in male patients with schizophrenia Y Shirayama, K Hashimoto, Y Suzuki, T Higuchi Schizophrenia research 58 (1), 69-74, 2002 | 142 | 2002 |
| The psychological aspects of patients with delayed sleep phase syndrome (DSPS) M Shirayama, Y Shirayama, H Iida, M Kato, N Kajimura, T Watanabe, ... Sleep medicine 4 (5), 427-433, 2003 | 141 | 2003 |
| Alterations in brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in the brain regions of a learned helplessness rat model and the antidepressant effects of a … Y Shirayama, C Yang, J Zhang, Q Ren, W Yao, K Hashimoto European Neuropsychopharmacology 25 (12), 2449-2458, 2015 | 136 | 2015 |
| Minocycline attenuates hyperlocomotion and prepulse inhibition deficits in mice after administration of the NMDA receptor antagonist dizocilpine L Zhang, Y Shirayama, M Iyo, K Hashimoto Neuropsychopharmacology 32 (9), 2004-2010, 2007 | 127 | 2007 |
| Lack of Antidepressant Effects of (2R,6R)-Hydroxynorketamine in a Rat Learned Helplessness Model: Comparison with (R)-Ketamine Y Shirayama, K Hashimoto International Journal of Neuropsychopharmacology 21 (1), 84-88, 2018 | 118 | 2018 |
| Specific metabolites in the medial prefrontal cortex are associated with the neurocognitive deficits in schizophrenia: a preliminary study Y Shirayama, T Obata, D Matsuzawa, H Nonaka, Y Kanazawa, ... Neuroimage 49 (3), 2783-2790, 2010 | 113 | 2010 |
| Plasma levels of homovanillic acid, 5-hydroxyindoleacetic acid and cortisol, and serotonin turnover in depressed patients H Mitani, Y Shirayama, T Yamada, R Kawahara Progress in Neuro-Psychopharmacology and Biological Psychiatry 30 (3), 531-534, 2006 | 113 | 2006 |
| AMPA receptor activation–independent antidepressant actions of ketamine metabolite (S)-norketamine C Yang, S Kobayashi, K Nakao, C Dong, M Han, Y Qu, Q Ren, J Zhang, ... Biological psychiatry 84 (8), 591-600, 2018 | 112 | 2018 |
Kenji Hashimoto, PhDChiba University在 faculty.chiba-u.jp 的電子郵件地址已通過驗證
